Strengthens cardiac care portfolio
Healthium Medtech, a global medtech company with a growing portfolio across surgical, post-surgical, advanced wound care, arthroscopy and infection prevention, has announced an exclusive partnership with US-based Tisgenx, the world’s leading manufacturer of bovine pericardial tissue patches. These patches, widely used in valve repair, vessel reconstruction and other complex cardiovascular and soft tissue interventions, are now made available to Indian surgeons through this collaboration. Under this agreement, Healthium has secured exclusive multiple rights to distribute Tisgenx’s products in India.
By expanding access to proven cardiac solutions, this partnership strengthens Healthium’s position in the cardiac care segment and reinforces its commitment to innovation-led, specialty-driven offerings. Known for their superior quality and reliability, the addition of Tisgenx’s pericardial tissue patches also aligns with Healthium’s focus on delivering high-performance, surgeon-centric innovations that simplify clinical decisions and support better healthcare outcomes.
Anish Bafna, CEO and MD, Healthium Medtech, said that the collaboration enhances the company’s cardiac care offerings and reinforces its commitment to providing high-quality, best-in-class products that resonate well with Indian surgeons. “We are proud to bring Tisgenx’s globally respected pericardial tissue patches to India through this exclusive partnership. As a homegrown medtech company, we remain focused on providing solutions that address the evolving needs of Indian surgeons and support them in their effort to deliver the best care for their patients,” he commented.
Kris Kupumbati, CEO and President, Tisgenx, noted that India is a strategic market for the company and expressed confidence in Healthium’s ability to deliver clinical value. “India represents one of the fastest-growing healthcare markets in the world and this exclusive partnership with Healthium allows us to play a meaningful role in advancing cardiac care here,” he said, adding, “Together, we are strengthening local access to global innovation and reinforcing our shared commitment to surgeon-centric, patient-first solutions.”
